Literature DB >> 25019697

Use of visible light spectroscopy to diagnose chronic gastrointestinal ischemia and predict response to treatment.

Aria Sana1, Leon M G Moons2, Bettina E Hansen3, Pieter Dewint4, Désirée van Noord4, Peter B F Mensink4, Ernst J Kuipers5.   

Abstract

BACKGROUND & AIMS: Chronic gastrointestinal ischemia (CGI) is more common than previously thought. Visible light spectroscopy (VLS) allows for noninvasive measurements of mucosal capillary hemoglobin oxygen saturation during endoscopy. We evaluated the response of patients with occlusive CGI to treatment after evaluation by radiologic imaging of the vasculature and VLS. We also identified factors associated with response to treatment in these patients.
METHODS: In a prospective study, we collected data from 212 patients referred for evaluation of suspected CGI from November 2008 through January 2011. Patients underwent an extensive evaluation that included visualization of gastrointestinal arteries and assessments of mucosal perfusion by means of VLS. Treatment response was evaluated in patients with occlusive CGI. Factors associated with response to therapy were assessed by using multivariate logistic regression analysis.
RESULTS: Occlusive CGI was diagnosed in 107 patients (50%); 96 were offered treatment (90%). After median follow-up period of 13 months, data on treatment response were available from 89 patients (93%); 62 patients had a sustained response (70%). Weight loss before treatment (odds ratio [OR], 1.93), presence of an abdominal bruit (OR, 2.36), and corpus mucosal saturation level <56% (OR, 4.84) were the strongest predictors of a positive response to treatment.
CONCLUSIONS: Treatment of CGI, diagnosed by a multimodal approach, provides a substantial long-term rate of response (70% in 13 months). Weight loss, abdominal bruit, and low corpus mucosal saturation identify patients most likely to respond to treatment. Multiple techniques should therefore be used to assess patients with CGI, including VLS measurements, to detect mucosal hypoxia.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastrointestinal Mucosal Perfusion; Hypoxia; Noninvasive Measurement

Mesh:

Year:  2014        PMID: 25019697     DOI: 10.1016/j.cgh.2014.07.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  4 in total

Review 1.  Clinical management of chronic mesenteric ischemia.

Authors:  Louisa Jd van Dijk; Desirée van Noord; Annemarie C de Vries; Jeroen J Kolkman; Robert H Geelkerken; Hence Jm Verhagen; Adriaan Moelker; Marco J Bruno
Journal:  United European Gastroenterol J       Date:  2018-12-04       Impact factor: 4.623

2.  Evaluation of endoscopic visible light spectroscopy: comparison with microvascular oxygen tension measurements in a porcine model.

Authors:  Rinse Ubbink; Louisa J D van Dijk; Desirée van Noord; Tanja Johannes; Patricia A C Specht; Marco J Bruno; Egbert G Mik
Journal:  J Transl Med       Date:  2019-02-28       Impact factor: 5.531

3.  Validation of a score chart to predict the risk of chronic mesenteric ischemia and development of an updated score chart.

Authors:  Louisa Jd van Dijk; Desirée van Noord; Robert H Geelkerken; Jihan Harki; Sophie A Berendsen; Annemarie C de Vries; Adriaan Moelker; Yvonne Vergouwe; Hence Jm Verhagen; Jeroen J Kolkman; Marco J Bruno
Journal:  United European Gastroenterol J       Date:  2019-06-04       Impact factor: 4.623

4.  Case report: Early detection of mesenteric ischemia by intravital microscopy in a patient with septic shock.

Authors:  Janina Praxenthaler; Carmen Kirchner; Elke Schwier; Simon Altmann; Axel Wittmer; Dietrich Henzler; Thomas Köhler
Journal:  Front Med (Lausanne)       Date:  2022-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.